Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Crossover Study to Assess the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol Intoxication (METAL-2)
Conditions
Interventions
FSD-F2R6-A-CP
Placebo
Locations
1
United States
Applied Science and Performance Institute
Tampa, Florida, United States
Start Date
July 12, 2024
Primary Completion Date
November 7, 2024
Completion Date
November 7, 2024
Last Updated
May 22, 2025
Lead Sponsor
Quantum Biopharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions